Change my location 
U.S. Federal Reserve
|
Stocks end higher following economic readings
Wall Street ended a volatile week with uneven gains Friday after better-than-expected economic data placated a market pummeled a day earlier by concerns about housing and the financial sector.
Miami judge issues injunction for finance group
A Miami federal judge on Friday toughened an order against a group that promotes its own currency and says it wants to seize control of Bank of America and more than $15 billion from its branches.
Banks step up Fed borrowing, Wall Street passes
Banks stepped up their borrowing over the past week from the Federal Reserve's emergency lending program, while Wall Street firms didn't draw such loans.
All types of mortgages see rate increases
Mortgage rates shot up this week with 30-year mortgages climbing to the highest level in nearly a year, reflecting concerns in financial markets about the troubles at corporate giants Fannie Mae and Freddie Mac.  Paulson says financial stability is top priorityTreasury Secretary Henry Paulson spent another day stumping for the U.S. banking system, declaring Tuesday that his top priority was ensuring "stability and confidence in our markets and financial institutions."
Fed Reserve inflation hawk: Rates should go up
To fend off inflation, the Federal Reserve probably will need to boost interest rates "sooner rather than later" even if employment and financial conditions haven't revived, the president of the Federal Reserve Bank of Philadelphia said Tuesday.
Irwin Stelzer: Is the worst behind us?
T hat jump in share prices (even after Monday’s tiny dip): Start of a recovery from a market bottom, or a “dead cat bounce” typical of bear markets? That drop in oil prices: the end of successive increases, or a pause before we head to $200 oil?  Roche offers $43.7B for rest of GenentechSwiss pharmaceutical maker Roche on Monday offered $43.7 billion for the remaining shares of its U.S. biotech partner Genentech Inc., seizing the opportunity offered by the weak U.S. dollar to grab a bigger share of earnings from such Genentech drugs as the blockbuster cancer treatment Avastin.
Economists: 2nd half growth likely to be anemic
Call it the big fizzle. The hoped-for second-half economic rebound is looking to be lethargic, with the country straining under high energy prices and fallout from the housing and credit debacles.  Wall Street awaits banks, housing, oil dataWall Street surged higher last week, but that's cold comfort to people whose stock portfolios are still down more than 10 percent this year.
|
 ARTICLES  BLOGS  AUDIO  |